open access

Vol 81, No 4 (2013)
CASE REPORTS
Submitted: 2013-06-07
Accepted: 2013-06-07
Get Citation

Severe Legionella pneumophila pneumonia and non-invasive ventilation: presentation of two cases and brief review of the literature

Antonello Nicolini, Gianluca Ferraioli, Renata Senarega
Pneumonol Alergol Pol 2013;81(4):399-403.

open access

Vol 81, No 4 (2013)
CASE REPORTS
Submitted: 2013-06-07
Accepted: 2013-06-07

Abstract

Legionella pneumophila is an agent also well known to be frequently responsible for severe community acquired pneumonia. Recent studies regarding severe community-acquired pneumonia have shown that Legionella pneumophila is the second most common cause of admission to ICU, not far behind pneumococcal pneumonia. The mortality of severe Legionella pneumonia is high (30%). We report two cases of severe respiratory failure due to Legionella pneumophila type 1 treated with non-invasive ventilation in the Respiratory Intermediate Care Unit of a Department of Respiratory Medicine with good outcomes. Severe community-acquired pneumonia is the most common cause of ARDS, and it is the primary reason for Intensive Care Unit admission with invasive mechanical ventilation. Delay in ICU admission is probably associated with a poorer outcome. The use of non-invasive ventilation in severe community acquired pneumonia is controversial. However, after recent pandemics, the number of studies reporting good rates of success for NIV has increased. Both our patients were managed in a respiratory intermediate care unit, avoiding invasive ventilation and invasive monitoring, which lowered costs yet was equally effective in providing a good outcome when compared to intubation in the Intensive Care Unit.

Abstract

Legionella pneumophila is an agent also well known to be frequently responsible for severe community acquired pneumonia. Recent studies regarding severe community-acquired pneumonia have shown that Legionella pneumophila is the second most common cause of admission to ICU, not far behind pneumococcal pneumonia. The mortality of severe Legionella pneumonia is high (30%). We report two cases of severe respiratory failure due to Legionella pneumophila type 1 treated with non-invasive ventilation in the Respiratory Intermediate Care Unit of a Department of Respiratory Medicine with good outcomes. Severe community-acquired pneumonia is the most common cause of ARDS, and it is the primary reason for Intensive Care Unit admission with invasive mechanical ventilation. Delay in ICU admission is probably associated with a poorer outcome. The use of non-invasive ventilation in severe community acquired pneumonia is controversial. However, after recent pandemics, the number of studies reporting good rates of success for NIV has increased. Both our patients were managed in a respiratory intermediate care unit, avoiding invasive ventilation and invasive monitoring, which lowered costs yet was equally effective in providing a good outcome when compared to intubation in the Intensive Care Unit.

Get Citation

Keywords

severe community-acquired pneumonia, severe respiratory failure, Legionella pneumophila, non-invasive ventilation, non-invasive monitoring

About this article
Title

Severe Legionella pneumophila pneumonia and non-invasive ventilation: presentation of two cases and brief review of the literature

Journal

Advances in Respiratory Medicine

Issue

Vol 81, No 4 (2013)

Pages

399-403

Bibliographic record

Pneumonol Alergol Pol 2013;81(4):399-403.

Keywords

severe community-acquired pneumonia
severe respiratory failure
Legionella pneumophila
non-invasive ventilation
non-invasive monitoring

Authors

Antonello Nicolini
Gianluca Ferraioli
Renata Senarega

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl